Share Price and Basic Stock Data
Last Updated: January 29, 2026, 11:18 am
| PEG Ratio | 11.26 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Clean Science & Technology Ltd operates within the specialty chemicals sector, focusing on environmentally friendly products. The company reported a market capitalization of ₹9,124 Cr, with a current share price of ₹859. Revenue from operations exhibited a fluctuating trend, peaking at ₹936 Cr for the fiscal year ending March 2023, before declining to ₹791 Cr for the fiscal year ending March 2024. However, it rebounded to ₹967 Cr in March 2025, with a trailing twelve-month revenue of ₹992 Cr. Quarterly sales figures revealed a decreasing pattern in the latter half of 2023, with sales standing at ₹181 Cr in September 2023 but recovering to ₹195 Cr by December 2023. The company’s sales for March 2025 are projected at ₹264 Cr, indicating a potential return to growth. The operating profit margin (OPM) has remained relatively strong, reported at 36% in the latest data, underscoring the company’s ability to maintain profitability even amid revenue fluctuations.
Profitability and Efficiency Metrics
Clean Science & Technology Ltd’s profitability metrics reflect a robust operational performance. The company recorded a net profit of ₹264 Cr for the fiscal year ending March 2025, with an impressive net profit margin of 27.35%. The return on equity (ROE) stood at 20.2%, while the return on capital employed (ROCE) was reported at 27.3%. These figures highlight the company’s effective management of shareholders’ equity and capital. Additionally, the interest coverage ratio (ICR) was extraordinarily high at 1024.52x, indicating minimal reliance on debt and a strong capacity to cover interest obligations. However, the cash conversion cycle (CCC) has lengthened to 129 days, reflecting challenges in working capital management. The operating profit margin (OPM) has seen a slight decline to 40% for the fiscal year ending March 2025, which could be indicative of rising operational costs or pricing pressures in the specialty chemicals market.
Balance Sheet Strength and Financial Ratios
Clean Science & Technology Ltd maintains a solid balance sheet characterized by low borrowings of just ₹2 Cr, showcasing prudent financial management. The company’s total assets stood at ₹1,684 Cr, with total liabilities at ₹1,600 Cr, resulting in a healthy equity base. Reserves have steadily increased, reaching ₹1,489 Cr by September 2025, which provides a cushion for future growth initiatives. The book value per share, including revaluation reserves, was reported at ₹133.28, up from ₹113.24 the previous year. The company’s current ratio of 5.14 indicates robust liquidity, well above the typical threshold of 1.5 for healthy operations. Furthermore, a price-to-book value (P/BV) ratio of 8.76x suggests that the stock is trading at a premium compared to its book value, which may reflect investor confidence in future growth prospects. However, the increasing P/BV ratio could also indicate overvaluation concerns in the context of market corrections.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Clean Science & Technology Ltd demonstrates a notable shift in investor confidence. Promoters held 50.96% of the shares as of September 2025, a significant decline from 78.50% in December 2022. This reduction raises questions about the promoters’ commitment and may concern investors. Conversely, foreign institutional investors (FIIs) have increased their stake to 11.14%, while domestic institutional investors (DIIs) have also raised their holdings to 18.97%. The public shareholding now stands at 18.91%, indicating a diversified ownership structure. The total number of shareholders has also fluctuated, with 239,974 shareholders recorded in September 2025. This diversified shareholding can be seen as a strength, potentially stabilizing the stock against volatility. However, the declining promoter shareholding could lead to scrutiny regarding future governance and strategic direction.
Outlook, Risks, and Final Insight
Looking ahead, Clean Science & Technology Ltd faces both opportunities and challenges. The rebound in revenue for March 2025, alongside strong profitability metrics, positions the company favorably within the specialty chemicals sector. However, the increasing cash conversion cycle and declining promoter shareholding pose risks that could impact operational efficiency and investor confidence. The company’s ability to manage working capital effectively will be crucial in sustaining profitability in a competitive market landscape. Additionally, fluctuations in raw material prices and regulatory changes could affect margins. The company’s strong balance sheet and low debt levels provide a buffer against economic uncertainties. Overall, while Clean Science & Technology Ltd exhibits strong fundamentals, its future performance will depend on strategic management of both growth opportunities and inherent risks in the specialty chemicals market.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 355 Cr. | 38.6 | 71.2/36.4 | 22.0 | 20.5 | 1.03 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 28.0 Cr. | 57.0 | 88.8/52.0 | 13.4 | 89.6 | 1.76 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 46.6 Cr. | 685 | 899/600 | 21.5 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,251 Cr. | 71.7 | 111/68.2 | 21.5 | 22.0 | 0.68 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 568 Cr. | 228 | 377/208 | 20.4 | 93.8 | 1.09 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,093.20 Cr | 656.92 | 58.13 | 182.97 | 0.47% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 248 | 237 | 217 | 188 | 181 | 195 | 228 | 224 | 238 | 241 | 264 | 243 | 245 |
| Expenses | 150 | 129 | 112 | 112 | 106 | 108 | 133 | 129 | 148 | 142 | 159 | 143 | 158 |
| Operating Profit | 97 | 108 | 105 | 76 | 75 | 87 | 95 | 95 | 90 | 98 | 105 | 100 | 87 |
| OPM % | 39% | 46% | 48% | 40% | 41% | 44% | 42% | 42% | 38% | 41% | 40% | 41% | 36% |
| Other Income | 3 | 13 | 13 | 13 | 6 | 8 | 14 | 10 | 11 | 5 | 12 | 13 | 7 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 9 | 9 | 10 | 11 | 11 | 11 | 13 | 16 | 18 | 18 | 17 | 19 | 19 |
| Profit before tax | 92 | 112 | 108 | 79 | 69 | 83 | 95 | 89 | 83 | 85 | 100 | 95 | 75 |
| Tax % | 26% | 25% | 25% | 25% | 25% | 25% | 26% | 26% | 29% | 23% | 26% | 26% | 26% |
| Net Profit | 68 | 84 | 81 | 59 | 52 | 63 | 70 | 66 | 59 | 66 | 74 | 70 | 55 |
| EPS in Rs | 6.40 | 7.89 | 7.58 | 5.55 | 4.91 | 5.89 | 6.61 | 6.20 | 5.53 | 6.18 | 6.97 | 6.59 | 5.22 |
Last Updated: January 10, 2026, 9:48 am
Below is a detailed analysis of the quarterly data for Clean Science & Technology Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 245.00 Cr.. The value appears strong and on an upward trend. It has increased from 243.00 Cr. (Jun 2025) to 245.00 Cr., marking an increase of 2.00 Cr..
- For Expenses, as of Sep 2025, the value is 158.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 143.00 Cr. (Jun 2025) to 158.00 Cr., marking an increase of 15.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 87.00 Cr.. The value appears to be declining and may need further review. It has decreased from 100.00 Cr. (Jun 2025) to 87.00 Cr., marking a decrease of 13.00 Cr..
- For OPM %, as of Sep 2025, the value is 36.00%. The value appears to be declining and may need further review. It has decreased from 41.00% (Jun 2025) to 36.00%, marking a decrease of 5.00%.
- For Other Income, as of Sep 2025, the value is 7.00 Cr.. The value appears to be declining and may need further review. It has decreased from 13.00 Cr. (Jun 2025) to 7.00 Cr., marking a decrease of 6.00 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 19.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 19.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 75.00 Cr.. The value appears to be declining and may need further review. It has decreased from 95.00 Cr. (Jun 2025) to 75.00 Cr., marking a decrease of 20.00 Cr..
- For Tax %, as of Sep 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 26.00%.
- For Net Profit, as of Sep 2025, the value is 55.00 Cr.. The value appears to be declining and may need further review. It has decreased from 70.00 Cr. (Jun 2025) to 55.00 Cr., marking a decrease of 15.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 5.22. The value appears to be declining and may need further review. It has decreased from 6.59 (Jun 2025) to 5.22, marking a decrease of 1.37.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:32 am
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 241 | 393 | 419 | 512 | 685 | 936 | 791 | 967 | 992 |
| Expenses | 167 | 257 | 234 | 253 | 385 | 533 | 459 | 579 | 602 |
| Operating Profit | 74 | 137 | 186 | 260 | 300 | 403 | 332 | 388 | 390 |
| OPM % | 31% | 35% | 44% | 51% | 44% | 43% | 42% | 40% | 39% |
| Other Income | 5 | 11 | 11 | 25 | 30 | 30 | 41 | 39 | 38 |
| Interest | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 |
| Depreciation | 8 | 11 | 14 | 17 | 25 | 36 | 46 | 69 | 73 |
| Profit before tax | 70 | 137 | 182 | 267 | 305 | 396 | 326 | 357 | 354 |
| Tax % | 30% | 28% | 23% | 26% | 25% | 25% | 25% | 26% | |
| Net Profit | 49 | 98 | 140 | 198 | 228 | 295 | 244 | 264 | 265 |
| EPS in Rs | 345.41 | 689.84 | 1,051.67 | 18.68 | 21.51 | 27.78 | 22.97 | 24.88 | 24.96 |
| Dividend Payout % | 12% | 15% | 2% | 134% | 15% | 18% | 22% | 24% |
YoY Net Profit Growth
| Year | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 100.00% | 42.86% | 41.43% | 15.15% | 29.39% | -17.29% | 8.20% |
| Change in YoY Net Profit Growth (%) | 0.00% | -57.14% | -1.43% | -26.28% | 14.23% | -46.67% | 25.48% |
Clean Science & Technology Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2018-2019 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 18% |
| 3 Years: | 12% |
| TTM: | 19% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 5% |
| TTM: | 7% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -14% |
| 1 Year: | -23% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 28% |
| 3 Years: | 24% |
| Last Year: | 20% |
Last Updated: September 5, 2025, 1:41 pm
Balance Sheet
Last Updated: December 4, 2025, 2:05 am
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 186 | 271 | 341 | 529 | 758 | 999 | 1,193 | 1,406 | 1,489 |
| Borrowings | 1 | 3 | 3 | 0 | 0 | 2 | 2 | 2 | 2 |
| Other Liabilities | 48 | 53 | 85 | 120 | 156 | 140 | 191 | 181 | 182 |
| Total Liabilities | 236 | 327 | 430 | 660 | 925 | 1,152 | 1,396 | 1,600 | 1,684 |
| Fixed Assets | 102 | 127 | 166 | 186 | 296 | 460 | 636 | 715 | 689 |
| CWIP | 2 | 4 | 3 | 55 | 44 | 20 | 57 | 30 | 98 |
| Investments | 18 | 75 | 133 | 232 | 191 | 353 | 339 | 381 | 432 |
| Other Assets | 114 | 121 | 128 | 187 | 394 | 318 | 364 | 474 | 466 |
| Total Assets | 236 | 327 | 430 | 660 | 925 | 1,152 | 1,396 | 1,600 | 1,684 |
Below is a detailed analysis of the balance sheet data for Clean Science & Technology Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 11.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,489.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,406.00 Cr. (Mar 2025) to 1,489.00 Cr., marking an increase of 83.00 Cr..
- For Borrowings, as of Sep 2025, the value is 2.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 182.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 181.00 Cr. (Mar 2025) to 182.00 Cr., marking an increase of 1.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,684.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,600.00 Cr. (Mar 2025) to 1,684.00 Cr., marking an increase of 84.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 689.00 Cr.. The value appears to be declining and may need further review. It has decreased from 715.00 Cr. (Mar 2025) to 689.00 Cr., marking a decrease of 26.00 Cr..
- For CWIP, as of Sep 2025, the value is 98.00 Cr.. The value appears strong and on an upward trend. It has increased from 30.00 Cr. (Mar 2025) to 98.00 Cr., marking an increase of 68.00 Cr..
- For Investments, as of Sep 2025, the value is 432.00 Cr.. The value appears strong and on an upward trend. It has increased from 381.00 Cr. (Mar 2025) to 432.00 Cr., marking an increase of 51.00 Cr..
- For Other Assets, as of Sep 2025, the value is 466.00 Cr.. The value appears to be declining and may need further review. It has decreased from 474.00 Cr. (Mar 2025) to 466.00 Cr., marking a decrease of 8.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,684.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,600.00 Cr. (Mar 2025) to 1,684.00 Cr., marking an increase of 84.00 Cr..
Notably, the Reserves (1,489.00 Cr.) exceed the Borrowings (2.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 73.00 | 134.00 | 183.00 | 260.00 | 300.00 | 401.00 | 330.00 | 386.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 60 | 55 | 61 | 53 | 82 | 57 | 76 | 77 |
| Inventory Days | 93 | 79 | 98 | 156 | 143 | 122 | 163 | 156 |
| Days Payable | 85 | 48 | 101 | 180 | 166 | 90 | 139 | 103 |
| Cash Conversion Cycle | 69 | 87 | 58 | 29 | 59 | 89 | 99 | 129 |
| Working Capital Days | 60 | 62 | 33 | 32 | 90 | 68 | 86 | 105 |
| ROCE % | 59% | 59% | 61% | 47% | 44% | 29% | 27% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Small Cap Fund | 3,091,186 | 0.4 | 270.8 | 3,039,656 | 2026-01-25 02:17:23 | 1.7% |
| SBI Small Cap Fund | 2,190,596 | 0.53 | 191.91 | N/A | N/A | N/A |
| UTI Flexi Cap Fund | 1,577,000 | 0.55 | 138.15 | 1,520,000 | 2025-12-14 09:17:31 | 3.75% |
| Nippon India Multi Cap Fund | 1,409,193 | 0.25 | 123.45 | 862,926 | 2025-12-15 04:02:53 | 63.3% |
| SBI MNC Fund | 1,000,000 | 1.5 | 87.61 | N/A | N/A | N/A |
| Axis ELSS Tax Saver Fund | 747,849 | 0.19 | 65.52 | 878,470 | 2025-11-03 09:12:52 | -14.87% |
| Edelweiss Small Cap Fund | 614,757 | 1.05 | 56.16 | N/A | N/A | N/A |
| HDFC Manufacturing Fund | 391,017 | 0.31 | 34.26 | N/A | N/A | N/A |
| UTI Small Cap Fund | 356,238 | 0.66 | 31.21 | N/A | N/A | N/A |
| JM Flexicap Fund | 350,723 | 0.56 | 30.73 | 385,000 | 2026-01-25 10:43:05 | -8.9% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 24.88 | 22.97 | 27.79 | 21.51 | 18.68 |
| Diluted EPS (Rs.) | 24.88 | 22.96 | 27.78 | 21.51 | 18.68 |
| Cash EPS (Rs.) | 31.38 | 27.29 | 31.18 | 23.86 | 20.30 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 133.28 | 113.24 | 95.07 | 72.34 | 50.81 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 133.28 | 113.24 | 95.07 | 72.34 | 50.81 |
| Revenue From Operations / Share (Rs.) | 90.96 | 74.49 | 88.08 | 64.48 | 48.24 |
| PBDIT / Share (Rs.) | 40.11 | 35.14 | 40.66 | 31.05 | 26.79 |
| PBIT / Share (Rs.) | 33.61 | 30.82 | 37.26 | 28.71 | 25.17 |
| PBT / Share (Rs.) | 33.57 | 30.73 | 37.24 | 28.69 | 25.16 |
| Net Profit / Share (Rs.) | 24.88 | 22.97 | 27.78 | 21.51 | 18.68 |
| NP After MI And SOA / Share (Rs.) | 24.88 | 22.97 | 27.78 | 21.51 | 18.68 |
| PBDIT Margin (%) | 44.09 | 47.17 | 46.15 | 48.16 | 55.53 |
| PBIT Margin (%) | 36.94 | 41.36 | 42.29 | 44.52 | 52.18 |
| PBT Margin (%) | 36.90 | 41.25 | 42.27 | 44.50 | 52.16 |
| Net Profit Margin (%) | 27.35 | 30.83 | 31.54 | 33.36 | 38.71 |
| NP After MI And SOA Margin (%) | 27.35 | 30.83 | 31.54 | 33.36 | 38.71 |
| Return on Networth / Equity (%) | 18.66 | 20.28 | 29.22 | 29.73 | 36.75 |
| Return on Capital Employeed (%) | 24.59 | 26.48 | 38.19 | 38.61 | 47.92 |
| Return On Assets (%) | 16.44 | 17.47 | 25.62 | 24.71 | 30.06 |
| Asset Turnover Ratio (%) | 0.64 | 0.62 | 0.89 | 0.86 | 0.94 |
| Current Ratio (X) | 5.14 | 4.12 | 5.46 | 4.23 | 3.87 |
| Quick Ratio (X) | 4.18 | 3.35 | 4.51 | 3.57 | 3.36 |
| Inventory Turnover Ratio (X) | 7.08 | 2.43 | 3.44 | 3.48 | 3.15 |
| Dividend Payout Ratio (NP) (%) | 20.09 | 21.76 | 18.89 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 15.93 | 18.32 | 16.83 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 79.91 | 78.24 | 81.11 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 84.07 | 81.68 | 83.17 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 1024.52 | 403.19 | 2214.97 | 2243.95 | 3127.44 |
| Interest Coverage Ratio (Post Tax) (X) | 636.59 | 264.53 | 1514.72 | 1555.39 | 2181.00 |
| Enterprise Value (Cr.) | 12383.61 | 14100.43 | 13420.03 | 21095.82 | 0.00 |
| EV / Net Operating Revenue (X) | 12.81 | 17.82 | 14.34 | 30.80 | 0.00 |
| EV / EBITDA (X) | 29.06 | 37.77 | 31.07 | 63.95 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 12.83 | 17.83 | 14.35 | 30.91 | 0.00 |
| Retention Ratios (%) | 79.90 | 78.23 | 81.10 | 0.00 | 0.00 |
| Price / BV (X) | 8.76 | 11.73 | 13.30 | 27.55 | 0.00 |
| Price / Net Operating Revenue (X) | 12.83 | 17.83 | 14.35 | 30.91 | 0.00 |
| EarningsYield | 0.02 | 0.01 | 0.02 | 0.01 | 0.00 |
After reviewing the key financial ratios for Clean Science & Technology Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 24.88. This value is within the healthy range. It has increased from 22.97 (Mar 24) to 24.88, marking an increase of 1.91.
- For Diluted EPS (Rs.), as of Mar 25, the value is 24.88. This value is within the healthy range. It has increased from 22.96 (Mar 24) to 24.88, marking an increase of 1.92.
- For Cash EPS (Rs.), as of Mar 25, the value is 31.38. This value is within the healthy range. It has increased from 27.29 (Mar 24) to 31.38, marking an increase of 4.09.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 133.28. It has increased from 113.24 (Mar 24) to 133.28, marking an increase of 20.04.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 133.28. It has increased from 113.24 (Mar 24) to 133.28, marking an increase of 20.04.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 90.96. It has increased from 74.49 (Mar 24) to 90.96, marking an increase of 16.47.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 40.11. This value is within the healthy range. It has increased from 35.14 (Mar 24) to 40.11, marking an increase of 4.97.
- For PBIT / Share (Rs.), as of Mar 25, the value is 33.61. This value is within the healthy range. It has increased from 30.82 (Mar 24) to 33.61, marking an increase of 2.79.
- For PBT / Share (Rs.), as of Mar 25, the value is 33.57. This value is within the healthy range. It has increased from 30.73 (Mar 24) to 33.57, marking an increase of 2.84.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 24.88. This value is within the healthy range. It has increased from 22.97 (Mar 24) to 24.88, marking an increase of 1.91.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 24.88. This value is within the healthy range. It has increased from 22.97 (Mar 24) to 24.88, marking an increase of 1.91.
- For PBDIT Margin (%), as of Mar 25, the value is 44.09. This value is within the healthy range. It has decreased from 47.17 (Mar 24) to 44.09, marking a decrease of 3.08.
- For PBIT Margin (%), as of Mar 25, the value is 36.94. This value exceeds the healthy maximum of 20. It has decreased from 41.36 (Mar 24) to 36.94, marking a decrease of 4.42.
- For PBT Margin (%), as of Mar 25, the value is 36.90. This value is within the healthy range. It has decreased from 41.25 (Mar 24) to 36.90, marking a decrease of 4.35.
- For Net Profit Margin (%), as of Mar 25, the value is 27.35. This value exceeds the healthy maximum of 10. It has decreased from 30.83 (Mar 24) to 27.35, marking a decrease of 3.48.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 27.35. This value exceeds the healthy maximum of 20. It has decreased from 30.83 (Mar 24) to 27.35, marking a decrease of 3.48.
- For Return on Networth / Equity (%), as of Mar 25, the value is 18.66. This value is within the healthy range. It has decreased from 20.28 (Mar 24) to 18.66, marking a decrease of 1.62.
- For Return on Capital Employeed (%), as of Mar 25, the value is 24.59. This value is within the healthy range. It has decreased from 26.48 (Mar 24) to 24.59, marking a decrease of 1.89.
- For Return On Assets (%), as of Mar 25, the value is 16.44. This value is within the healthy range. It has decreased from 17.47 (Mar 24) to 16.44, marking a decrease of 1.03.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.64. It has increased from 0.62 (Mar 24) to 0.64, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 5.14. This value exceeds the healthy maximum of 3. It has increased from 4.12 (Mar 24) to 5.14, marking an increase of 1.02.
- For Quick Ratio (X), as of Mar 25, the value is 4.18. This value exceeds the healthy maximum of 2. It has increased from 3.35 (Mar 24) to 4.18, marking an increase of 0.83.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.08. This value is within the healthy range. It has increased from 2.43 (Mar 24) to 7.08, marking an increase of 4.65.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 20.09. This value is within the healthy range. It has decreased from 21.76 (Mar 24) to 20.09, marking a decrease of 1.67.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 15.93. This value is below the healthy minimum of 20. It has decreased from 18.32 (Mar 24) to 15.93, marking a decrease of 2.39.
- For Earning Retention Ratio (%), as of Mar 25, the value is 79.91. This value exceeds the healthy maximum of 70. It has increased from 78.24 (Mar 24) to 79.91, marking an increase of 1.67.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 84.07. This value exceeds the healthy maximum of 70. It has increased from 81.68 (Mar 24) to 84.07, marking an increase of 2.39.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1,024.52. This value is within the healthy range. It has increased from 403.19 (Mar 24) to 1,024.52, marking an increase of 621.33.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 636.59. This value is within the healthy range. It has increased from 264.53 (Mar 24) to 636.59, marking an increase of 372.06.
- For Enterprise Value (Cr.), as of Mar 25, the value is 12,383.61. It has decreased from 14,100.43 (Mar 24) to 12,383.61, marking a decrease of 1,716.82.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 12.81. This value exceeds the healthy maximum of 3. It has decreased from 17.82 (Mar 24) to 12.81, marking a decrease of 5.01.
- For EV / EBITDA (X), as of Mar 25, the value is 29.06. This value exceeds the healthy maximum of 15. It has decreased from 37.77 (Mar 24) to 29.06, marking a decrease of 8.71.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 12.83. This value exceeds the healthy maximum of 3. It has decreased from 17.83 (Mar 24) to 12.83, marking a decrease of 5.00.
- For Retention Ratios (%), as of Mar 25, the value is 79.90. This value exceeds the healthy maximum of 70. It has increased from 78.23 (Mar 24) to 79.90, marking an increase of 1.67.
- For Price / BV (X), as of Mar 25, the value is 8.76. This value exceeds the healthy maximum of 3. It has decreased from 11.73 (Mar 24) to 8.76, marking a decrease of 2.97.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 12.83. This value exceeds the healthy maximum of 3. It has decreased from 17.83 (Mar 24) to 12.83, marking a decrease of 5.00.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Clean Science & Technology Ltd:
- Net Profit Margin: 27.35%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 24.59% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 18.66% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 636.59
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 4.18
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 34 (Industry average Stock P/E: 58.13)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 27.35%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Office No. 603 & 604, 6th Floor, Tower No. 15, Cybercity, Pune Maharashtra 411013 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Pradeep Rathi | Chairman & Non-Exe.Director |
| Mr. Ashok Boob | Managing Director |
| Mr. Siddhartha Sikchi | Executive Director |
| Mr. Krishnakumar Boob | Executive Director |
| Mr. Parth Maheshwari | Executive Director |
| Mr. Sanjay Kothari | Non Executive Director |
| Mr. Keval Doshi | Ind. Non-Executive Director |
| Ms. Madhu Dubhashi | Ind. Non-Executive Director |
| Prof. Ganapati Yadav | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Clean Science & Technology Ltd?
Clean Science & Technology Ltd's intrinsic value (as of 29 January 2026) is ₹803.69 which is 5.23% lower the current market price of ₹848.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹9,018 Cr. market cap, FY2025-2026 high/low of ₹1,600/834, reserves of ₹1,489 Cr, and liabilities of ₹1,684 Cr.
What is the Market Cap of Clean Science & Technology Ltd?
The Market Cap of Clean Science & Technology Ltd is 9,018 Cr..
What is the current Stock Price of Clean Science & Technology Ltd as on 29 January 2026?
The current stock price of Clean Science & Technology Ltd as on 29 January 2026 is ₹848.
What is the High / Low of Clean Science & Technology Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Clean Science & Technology Ltd stocks is ₹1,600/834.
What is the Stock P/E of Clean Science & Technology Ltd?
The Stock P/E of Clean Science & Technology Ltd is 34.0.
What is the Book Value of Clean Science & Technology Ltd?
The Book Value of Clean Science & Technology Ltd is 141.
What is the Dividend Yield of Clean Science & Technology Ltd?
The Dividend Yield of Clean Science & Technology Ltd is 0.70 %.
What is the ROCE of Clean Science & Technology Ltd?
The ROCE of Clean Science & Technology Ltd is 27.3 %.
What is the ROE of Clean Science & Technology Ltd?
The ROE of Clean Science & Technology Ltd is 20.2 %.
What is the Face Value of Clean Science & Technology Ltd?
The Face Value of Clean Science & Technology Ltd is 1.00.